Matches 1 - 50 out of 262 1 2 3 4 5 6 >


Match Document Document Title
US20110046120 TREATMENT OF IMPULSE CONTROL DISORDERS  
The present disclosure provides methods and compositions for treating Impulse Control disorders including, for example, pathological gambling using α2-adrenergic agonists, β-adrenergic receptor...
US20140056999 TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM  
The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible...
US20120264703 Methods And Compositions For The Treatment Of Anxiety Disorders, Including Post Traumatic Stress Disorder (PTSD) And Related Central Nervous System (CNS) Disorders.  
The present invention provides novel methods and formulations for treating anxiety disorders, including Post Traumatic Stress Disorder, in human subjects employing coordinate treatment using α and...
US20110039926 USE OF ENANTIOMER (1S, 2R) MILNACIPRAN HYDROCHLORIDE FOR THE PREVENTIVE TREATMENT OF SUICIDAL BEHAVIOUR IN DEPRESSED PATIENTS  
The invention concerns the substantially pure (1S,2R) enantiomer of milnacipran hydrochloride for its use for treating patients suffering from psychiatric disorders, while reducing the risk of...
US20120178757 Method For The Prevention Of Cancer Metastasis  
A method is provided for the prevention of cancer metastasis in a patient comprising administering an adrenergic receptor antagonist to a patient in need thereof. The invention also includes an...
US20140086872 Methods of Treating a Subject for a Condition  
Methods are provided for treating a subject for at least one condition that includes inflammation, a blood clotting condition and autonomic nervous system dysfunction such as adrenergia, e.g.,...
US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System  
Methods are provided for treating a subject for a condition caused by an abnormality in the subject's autonomic nervous system. In accordance with the subject methods, at least a portion of a...
US20140348774 METHOD FOR TREATING WOUNDS AND TISSUE REPAIR  
The present inventions relate to a number of fields including wound healing, a waterless antibacterial disinfectant, a surgical scrub, insect repellant, and methods of treating traumatic injuries,...
US20110319490 METHODS AND COMPOSITIONS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME  
A method for a prevention and/or treatment of irritable bowel syndrome or amelioration of a symptom thereof in a subject, comprises administering to said subject an effective amount of a compound...
US20130317030 Methods for Diagnosis of Cardiovascular Disease  
This invention pertains to methods and compositions for the diagnosis and treatment of cardiovascular conditions. More specifically, the invention relates to isolated molecules that can be used to...
US20110269689 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS  
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent...
US20130161222 BEDBUGS ELIMINATOR  
This product is made of composition of Paraffin Oil (Kerosene) and 40% Solution of Denatonium Benzoate in EG. The content of Paraffin Oil would be 90% and 10% of 40% Soln. of D. B. E. G. The...
US20130303568 Substituted 2-Aminoacetamides and the Use Thereof  
The invention is directed to substituted 2-aminoacetamides represented by formula (II): and to pharmaceutically acceptable salts and prodrugs thereof, wherein the substituents are defined herein....
US20150148424 STABLE DOSAGE FORMS OF LEVOMILNACIPRAN  
The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using...
US20130253063 STABLE DOSAGE FORMS OF LEVOMILNACIPRAN  
The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using...
US20110144210 STABLE DOSAGE FORMS OF LEVOMILNACIPRAN  
The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using...
US20130210778 FORMULATION FOR THE PREVENTION OF CARDIOVASCULAR DISEASE  
This invention relates to a method for the prevention of cardiovascular disease, a formulation for the prevention of cardiovascular disease, the use of specified active principals for the...
US20150133407 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISORDERS  
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical...
US20110158983 COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES  
In alternative embodiments, this invention provides compositions and methods for treating cancer or any condition caused by dysfunctional cells, side effects from treatments for cancer or any...
US20120115804 COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING NEOPLASIA  
The invention features compositions and methods for characterizing the methylation status of the Vitamin D Receptor (VDR) in neoplasia (e.g., breast carcinoma), selecting an appropriate therapy,...
US20130109674 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS  
The present invention relates to, among other things, methods for treating trigeminal cephalgias such as migraine and migraine like headaches and other cerebrovascular conditions associated with...
US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications  
A method for treating diabetic complications by administration of a beta-blocker is disclosed. Diabetic complications arise from diabetes and have few or no existing treatment options. The present...
US20110281853 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION  
The present invention provides compositions and methods for treating or preventing atrial fibrillation (AF). In particular, the present invention provides administration of muscarinic receptor...
US20140023710 MILNACIPRAN FORMULATIONS  
The present invention provides formulations comprising milnacipran or pharmaceutically acceptable salts thereof (e.g., milnacipran hydrochloride), including immediate release formulations and...
US20150087610 Method of Modifying Fertility  
The present invention provides methods and compositions for modifying fertility in a male mammalian subject by contacting the subject's testis cells, germ cells or sperm with a sufficient amount...
US20100323897 FOAMABLE PESTICIDE COMPOSITIONS  
Ready-to-use foamable pesticide compositions that contain a particulate pesticide suspended therein and applicators for dispensing such compositions. Methods for treating pests such as arthropods...
US20150017099 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES  
The invention provides methods and compositions for the diagnosis, prognosis and treatment of respiratory tract diseases. Specifically, the invention provides diagnosis, prognosis and treatment of...
US20140018433 METHOD OF TREATING ANDROGEN RECEPTOR (AR) -POSITIVE BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARMS)  
This invention relates to the treatment of androgen receptor-positive breast cancer in a subject, for example a female subject. Accordingly, this invention provides methods of: a) treating a...
US20150132358 PUNCTAL PLUG WITH ACTIVE AGENT  
A method and apparatus for administering an active agent such as a medicine to a subject, uses an ocular implant such as a punctal plug, to which the active agent has been applied. The implant is...
US20120021989 GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION AND STROKE  
The invention relates to procedures and methods of determining a susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter and Stroke, by assessing the presence or...
US20120108570 Pharmacological Treatment for Sleep Apnea  
The present invention relates generally to pharmacological methods for the prevention of amelioration of sleep-related breathing disorders via administration of agents or combinations of agents...
US20120022086 CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS  
Novel compounds, compositions, and methods related to the activation of the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of...
US20060235027 Inhibitors of cdc25 phosphatases  
A method of inhibiting cdc25 phosphatases in warm-blooded animals comprising administering to warm-blooded animals in need thereof an effective amount of a compound of the formula wherein the...
US20110206781 METHOD TO MODULATE HEMATOPOIETIC STEM CELL GROWTH  
Described herein are methods, compositions and kits related to manipulating hematopoietic stem cells (HSC) and more particularly to methods, compositions and kits related to increasing the number...
US20090264479 Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases  
Several parasites responsible for mammalian diseases are dependent on cysteine protease for various life-cycle functions. Inhibition of these proteases can be useful in the treatment of these...
US20100197661 Method of Treating Neurological Diseases and Disorders  
The present invention provides methods for treating neurological diseases and disorders. Compounds that replace or enhance the function of SMN or alleviate or reduce a phenotype of cells with low...
US20140051764 SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS  
The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy) -2-hydroxy-2-methylpropanamide and process for producing the same.
US20130121919 HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF  
The invention provides for a method for screening compounds that bind to and modulate a histone acetyltransferase protein. The invention further provides methods for treating neurodegenerative...
US20120128805 LONG-LASTING GUSTATORY AND/OR OLFACTORY AVERSION VETERINARY COMPOSITIONS FOR BEHAVIOR MODIFICATION  
Disclosed herein are gustatory and/or olfactory aversion compositions comprising one or more bitterants and appropriate adhesives or tackifiers, and the like, which provide a long-lasting effect....
US20120252792 METHODS AND COMPOSITIONS FOR MODULATING RHO-MEDIATED GENE TRANSCRIPTION  
The invention provides methods, compositions, and kits for the inhibition of members of the Rho GTPase family. Specifically, the invention provides methods, compositions and kits for the...
US20050137265 Rapidly dissolving metoclopramide solid oral dosage and method thereof  
A solid metoclopramide oral dosage formulation, such as a lyophilized oral dosage, dissolves within the mouth within about 60 seconds or less. This formulation is used for abating manifestations...
US20120295982 TREATING HUMAN MALE COPD PATIENTS WITH ORAL BEDORADRINE  
A method of treating a human male patient is disclosed. Enterally administering bedoradrine or a pharmaceutically acceptable salt thereof to a human male patient who is suffering from a medical...
US20150153360 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target  
This invention pertains to methods and compositions for the diagnosis and treatment of cardiovascular conditions. More specifically, the invention relates to isolated molecules that can be used to...
US20050032903 Method for controlling fungal sieases in legumes  
The invention relates to a method for controlling rusts in legumes, which comprises treating the aerial plant part of the legumes with an aqueous preparation of a strobilurin-containing formulation.
US20150038574 Opsin-Binding Ligands, Compositions and Methods of Use  
Compounds and compositions are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as...
US20100267801 CYCLOHEXYL SULPHONES FOR TREATMENT OF CANCER  
Sulphones of formula (I) are disclosed for use in treatment of cancer.
US20090291988 Reversible Inhibitors of Monoamine Oxidase A and B  
The instant invention relates to compounds of formula I, diagrammed below, wherein R3, E, D and Y are defined in the application, which are useful as reversible inhibitors of monoamine oxidase-B...
US20100298399 Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy  
The present invention concerns the use of methods for evaluating β-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed...
US20110160230 Ceramic matrix for incorporating controlled release drugs, a tablet, method for obtaining the ceramic matrix and method for producing a tablet  
The present invention refers to a ceramic nanosystem constructed for releasing medications in a controlled manner, in the treatment of human beings and animals presenting an organic deficiency...
US20060046978 Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)  
This invention relates to novel compounds, compositions containing the compounds, that inhibit dipeptidyl peptidase (especially DPP-IV) and neprilysin (NEP, neutral endopeptidase) as well as...

Matches 1 - 50 out of 262 1 2 3 4 5 6 >